These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15123981)

  • 1. Terbutaline and methergine in look-alike packaging.
    Simpson KR
    MCN Am J Matern Child Nurs; 2004; 29(3):208. PubMed ID: 15123981
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing medication errors through naming, labeling, and packaging.
    Berman A
    J Med Syst; 2004 Feb; 28(1):9-29. PubMed ID: 15171066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary edema during terbutaline infusion against threatened premature labor].
    Rasmussen OB; Larsen B
    Ugeskr Laeger; 1993 Apr; 155(17):1303-4. PubMed ID: 8506581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation in pregnancy associated with oral terbutaline therapy.
    Lashgari S; Kueck AS; Oyelese Y
    Obstet Gynecol; 2003 Apr; 101(4):814. PubMed ID: 12681894
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute paraparesis due to terbutaline sulfate.
    Herskowitz A; Herskowitz B
    South Med J; 2002 Feb; 95(2):275-6. PubMed ID: 11846262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Look-alike, sound-alike oncology medications.
    Schulmeister L
    Clin J Oncol Nurs; 2006 Feb; 10(1):35-41. PubMed ID: 16482726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA works toward product naming, packaging guidance.
    Traynor K
    Am J Health Syst Pharm; 2010 Aug; 67(16):1308-10. PubMed ID: 20689116
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial fibrillation in pregnancy associated with oral terbutaline.
    Carson MP; Fisher AJ; Scorza WE
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1096-7. PubMed ID: 12423819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications.
    Kuczkowski KM; Benumof JL
    J Clin Anesth; 2003 Aug; 15(5):357-8. PubMed ID: 14507561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eclampsia with RCVS: Postpartum seizure provoked by methergine.
    Kirschen GW; Hoyt K; Johnson E; Patel S
    Pregnancy Hypertens; 2022 Mar; 27():131-133. PubMed ID: 35063759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripartum heart failure associated with prolonged tocolytic therapy.
    Lampert MB; Hibbard J; Weinert L; Briller J; Lindheimer M; Lang RM
    Am J Obstet Gynecol; 1993 Feb; 168(2):493-5. PubMed ID: 8438916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dosing of subcutaneous terbutaline pump tocolytic therapy is critical.
    Lam F
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1156-7. PubMed ID: 1415415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recurrent myocardial ischemia after spontaneous abortion secondary to oral ergotamine alkaloids].
    Martí V; Salas E; Torner P; Domínguez de las Rozas JM
    Med Clin (Barc); 1999 Dec; 113(19):758-9. PubMed ID: 10680136
    [No Abstract]   [Full Text] [Related]  

  • 14. Think about drug packaging.
    Prescrire Int; 2012 Dec; 21(133):284. PubMed ID: 23373090
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medication standard. Error management in Spitex].
    Schwarze T; Schneeberger M
    Krankenpfl Soins Infirm; 2008; 101(9):26-7. PubMed ID: 23189467
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1998 Jan; 279(1):9. PubMed ID: 9424027
    [No Abstract]   [Full Text] [Related]  

  • 17. The risks associated with the use of multidose vials.
    Paparella S
    J Emerg Nurs; 2006 Oct; 32(5):428-30. PubMed ID: 16997036
    [No Abstract]   [Full Text] [Related]  

  • 18. Paraplegia from accidental injection of potassium solution.
    Rendell-Baker L
    Anaesthesia; 1985 Sep; 40(9):912-3. PubMed ID: 4051159
    [No Abstract]   [Full Text] [Related]  

  • 19. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
    Elliott JP; Istwan NB; Rhea D; Stanziano G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum second degree heart block induced by Methergine.
    Gowri V; Al Hinai A
    Int J Gynaecol Obstet; 2003 May; 81(2):227-9. PubMed ID: 12706285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.